Weight loss drugs no longer require a doctor’s visit. Now, spas are getting into the game, too — and it’s become a very big business.

In the U.S., medical aesthetics practices are dominating the GLP-1 market, with more than half of locations offering the drugs, particularly compounded versions of semaglutide and tirzepatide. Many patients are flocking to these locations for the compounded versions of drugs like Ozempic and Mounjaro, which offer a lower price versus the brand name drugs. Compounded drugs average $350 for semaglutide and $485 for tirzeptatide monthly, per health care data and analytics firm Guidepoint Qsight.

“The most striking insight is that 61 percent of patients initiating GLP-1 treatment at aesthetic practices are entirely new to those practices,” said Erika Sheyn, s

See Full Page